nodes	percent_of_prediction	percent_of_DWPC	metapath
Fondaparinux sodium—SERPINC1—Glypican 1 network—FLT1—malignant glioma	0.0296	0.0564	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Intrinsic Pathway—KNG1—malignant glioma	0.0291	0.0554	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—CFH—malignant glioma	0.0258	0.0491	CbGpPWpGaD
Fondaparinux sodium—F10—Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus—F2—malignant glioma	0.0239	0.0454	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Common Pathway—F2—malignant glioma	0.0221	0.042	CbGpPWpGaD
Fondaparinux sodium—F10—Gamma-carboxylation of protein precursors—F2—malignant glioma	0.0217	0.0413	CbGpPWpGaD
Fondaparinux sodium—F10—Removal of aminoterminal propeptides from gamma-carboxylated proteins—F2—malignant glioma	0.0217	0.0413	CbGpPWpGaD
Fondaparinux sodium—Clotting—Temozolomide—malignant glioma	0.0197	0.0416	CcSEcCtD
Fondaparinux sodium—SERPINC1—Formation of Fibrin Clot (Clotting Cascade)—KNG1—malignant glioma	0.0196	0.0373	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Intrinsic Pathway—F2—malignant glioma	0.0188	0.0358	CbGpPWpGaD
Fondaparinux sodium—F10—Gamma-carboxylation, transport, and amino-terminal cleavage of proteins—F2—malignant glioma	0.0185	0.0352	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Glypican 1 network—FGFR1—malignant glioma	0.0181	0.0345	CbGpPWpGaD
Fondaparinux sodium—Haemorrhage intracranial—Temozolomide—malignant glioma	0.0172	0.0362	CcSEcCtD
Fondaparinux sodium—F10—Intrinsic Pathway—KNG1—malignant glioma	0.0164	0.0313	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—CFH—malignant glioma	0.0146	0.0277	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Glypican 1 network—FGF2—malignant glioma	0.0133	0.0252	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—KNG1—malignant glioma	0.0132	0.0251	CbGpPWpGaD
Fondaparinux sodium—F10—Beta2 integrin cell surface interactions—KNG1—malignant glioma	0.0132	0.0251	CbGpPWpGaD
Fondaparinux sodium—Cerebral haemorrhage—Carmustine—malignant glioma	0.0132	0.0278	CcSEcCtD
Fondaparinux sodium—Cerebral haemorrhage—Temozolomide—malignant glioma	0.0127	0.0268	CcSEcCtD
Fondaparinux sodium—SERPINC1—Formation of Fibrin Clot (Clotting Cascade)—F2—malignant glioma	0.0127	0.0241	CbGpPWpGaD
Fondaparinux sodium—F10—Common Pathway—F2—malignant glioma	0.0125	0.0237	CbGpPWpGaD
Fondaparinux sodium—F10—Formation of Fibrin Clot (Clotting Cascade)—KNG1—malignant glioma	0.0111	0.0211	CbGpPWpGaD
Fondaparinux sodium—F10—Intrinsic Pathway—F2—malignant glioma	0.0106	0.0202	CbGpPWpGaD
Fondaparinux sodium—F10—Blood Clotting Cascade—F2—malignant glioma	0.0106	0.0202	CbGpPWpGaD
Fondaparinux sodium—Thrombosis—Carmustine—malignant glioma	0.0103	0.0217	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—DOCK6—malignant glioma	0.00962	0.0183	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Glypican 1 network—VEGFA—malignant glioma	0.00942	0.0179	CbGpPWpGaD
Fondaparinux sodium—Necrosis—Carmustine—malignant glioma	0.00929	0.0196	CcSEcCtD
Fondaparinux sodium—Abscess—Carmustine—malignant glioma	0.00922	0.0194	CcSEcCtD
Fondaparinux sodium—Coagulopathy—Temozolomide—malignant glioma	0.00905	0.0191	CcSEcCtD
Fondaparinux sodium—F10—PTM: gamma carboxylation, hypusine formation and arylsulfatase activation—F2—malignant glioma	0.00876	0.0167	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—F2—malignant glioma	0.00854	0.0163	CbGpPWpGaD
Fondaparinux sodium—Extravasation—Carmustine—malignant glioma	0.00836	0.0176	CcSEcCtD
Fondaparinux sodium—Drug interaction—Carmustine—malignant glioma	0.00786	0.0166	CcSEcCtD
Fondaparinux sodium—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00775	0.0163	CcSEcCtD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—KNG1—malignant glioma	0.00747	0.0142	CbGpPWpGaD
Fondaparinux sodium—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00745	0.0157	CcSEcCtD
Fondaparinux sodium—F10—Formation of Fibrin Clot (Clotting Cascade)—F2—malignant glioma	0.00717	0.0136	CbGpPWpGaD
Fondaparinux sodium—Sepsis—Carmustine—malignant glioma	0.00633	0.0133	CcSEcCtD
Fondaparinux sodium—Phlebitis—Carmustine—malignant glioma	0.00614	0.0129	CcSEcCtD
Fondaparinux sodium—Swelling—Carmustine—malignant glioma	0.006	0.0126	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—ATP1B2—malignant glioma	0.00583	0.0111	CbGpPWpGaD
Fondaparinux sodium—Vascular purpura—Temozolomide—malignant glioma	0.00572	0.0121	CcSEcCtD
Fondaparinux sodium—Hot flush—Temozolomide—malignant glioma	0.00547	0.0115	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—DOCK6—malignant glioma	0.00544	0.0103	CbGpPWpGaD
Fondaparinux sodium—Menopausal symptoms—Temozolomide—malignant glioma	0.00542	0.0114	CcSEcCtD
Fondaparinux sodium—Purpura—Temozolomide—malignant glioma	0.00531	0.0112	CcSEcCtD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—F2—malignant glioma	0.00483	0.00918	CbGpPWpGaD
Fondaparinux sodium—Hypokalaemia—Carmustine—malignant glioma	0.00482	0.0102	CcSEcCtD
Fondaparinux sodium—Dehydration—Temozolomide—malignant glioma	0.00476	0.01	CcSEcCtD
Fondaparinux sodium—Hypokalaemia—Temozolomide—malignant glioma	0.00466	0.00981	CcSEcCtD
Fondaparinux sodium—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00461	0.00971	CcSEcCtD
Fondaparinux sodium—Dysphagia—Carmustine—malignant glioma	0.00457	0.00964	CcSEcCtD
Fondaparinux sodium—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00451	0.00951	CcSEcCtD
Fondaparinux sodium—Abdominal distension—Temozolomide—malignant glioma	0.00445	0.00938	CcSEcCtD
Fondaparinux sodium—Dysphagia—Temozolomide—malignant glioma	0.00442	0.00932	CcSEcCtD
Fondaparinux sodium—Sweating increased—Temozolomide—malignant glioma	0.00431	0.00908	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—ANGPT2—malignant glioma	0.0043	0.00818	CbGpPWpGaD
Fondaparinux sodium—Bronchitis—Temozolomide—malignant glioma	0.00425	0.00896	CcSEcCtD
Fondaparinux sodium—Renal failure—Carmustine—malignant glioma	0.00401	0.00845	CcSEcCtD
Fondaparinux sodium—Urinary tract infection—Carmustine—malignant glioma	0.00396	0.00836	CcSEcCtD
Fondaparinux sodium—Infestation—Temozolomide—malignant glioma	0.00394	0.00831	CcSEcCtD
Fondaparinux sodium—Infestation NOS—Temozolomide—malignant glioma	0.00394	0.00831	CcSEcCtD
Fondaparinux sodium—Urinary tract infection—Temozolomide—malignant glioma	0.00383	0.00807	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Temozolomide—malignant glioma	0.00373	0.00786	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—HIST1H3B—malignant glioma	0.00372	0.00708	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—MYB—malignant glioma	0.00369	0.00702	CbGpPWpGaD
Fondaparinux sodium—Haemoglobin—Carmustine—malignant glioma	0.00368	0.00776	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Carmustine—malignant glioma	0.00366	0.00772	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Carmustine—malignant glioma	0.00364	0.00768	CcSEcCtD
Fondaparinux sodium—Oedema peripheral—Carmustine—malignant glioma	0.00361	0.0076	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Temozolomide—malignant glioma	0.00356	0.0075	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Temozolomide—malignant glioma	0.00354	0.00746	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Temozolomide—malignant glioma	0.00352	0.00742	CcSEcCtD
Fondaparinux sodium—Oedema peripheral—Temozolomide—malignant glioma	0.00349	0.00735	CcSEcCtD
Fondaparinux sodium—Flushing—Carmustine—malignant glioma	0.0034	0.00716	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—ATP1B2—malignant glioma	0.00329	0.00627	CbGpPWpGaD
Fondaparinux sodium—Flushing—Temozolomide—malignant glioma	0.00328	0.00692	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Carmustine—malignant glioma	0.00327	0.00689	CcSEcCtD
Fondaparinux sodium—Angiopathy—Temozolomide—malignant glioma	0.00321	0.00677	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Temozolomide—malignant glioma	0.0032	0.00674	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Temozolomide—malignant glioma	0.00319	0.00672	CcSEcCtD
Fondaparinux sodium—Malnutrition—Carmustine—malignant glioma	0.00319	0.00672	CcSEcCtD
Fondaparinux sodium—Back pain—Carmustine—malignant glioma	0.00308	0.0065	CcSEcCtD
Fondaparinux sodium—Malnutrition—Temozolomide—malignant glioma	0.00308	0.00649	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Temozolomide—malignant glioma	0.00302	0.00636	CcSEcCtD
Fondaparinux sodium—Vision blurred—Carmustine—malignant glioma	0.003	0.00633	CcSEcCtD
Fondaparinux sodium—Back pain—Temozolomide—malignant glioma	0.00298	0.00628	CcSEcCtD
Fondaparinux sodium—Anaemia—Carmustine—malignant glioma	0.00295	0.00621	CcSEcCtD
Fondaparinux sodium—Vision blurred—Temozolomide—malignant glioma	0.0029	0.00612	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—H3F3A—malignant glioma	0.00287	0.00547	CbGpPWpGaD
Fondaparinux sodium—Anaemia—Temozolomide—malignant glioma	0.00285	0.006	CcSEcCtD
Fondaparinux sodium—Angioedema—Temozolomide—malignant glioma	0.00281	0.00593	CcSEcCtD
Fondaparinux sodium—Vertigo—Temozolomide—malignant glioma	0.00277	0.00583	CcSEcCtD
Fondaparinux sodium—Convulsion—Carmustine—malignant glioma	0.00276	0.00582	CcSEcCtD
Fondaparinux sodium—Palpitations—Temozolomide—malignant glioma	0.00272	0.00574	CcSEcCtD
Fondaparinux sodium—Chest pain—Carmustine—malignant glioma	0.00271	0.00572	CcSEcCtD
Fondaparinux sodium—Anxiety—Carmustine—malignant glioma	0.0027	0.0057	CcSEcCtD
Fondaparinux sodium—Cough—Temozolomide—malignant glioma	0.00269	0.00567	CcSEcCtD
Fondaparinux sodium—Convulsion—Temozolomide—malignant glioma	0.00267	0.00562	CcSEcCtD
Fondaparinux sodium—Confusional state—Carmustine—malignant glioma	0.00262	0.00553	CcSEcCtD
Fondaparinux sodium—Anxiety—Temozolomide—malignant glioma	0.00261	0.00551	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.0026	0.00549	CcSEcCtD
Fondaparinux sodium—Oedema—Carmustine—malignant glioma	0.0026	0.00548	CcSEcCtD
Fondaparinux sodium—Infection—Carmustine—malignant glioma	0.00258	0.00545	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Carmustine—malignant glioma	0.00255	0.00537	CcSEcCtD
Fondaparinux sodium—Tachycardia—Carmustine—malignant glioma	0.00254	0.00535	CcSEcCtD
Fondaparinux sodium—Confusional state—Temozolomide—malignant glioma	0.00253	0.00534	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Temozolomide—malignant glioma	0.00251	0.0053	CcSEcCtD
Fondaparinux sodium—Oedema—Temozolomide—malignant glioma	0.00251	0.0053	CcSEcCtD
Fondaparinux sodium—Infection—Temozolomide—malignant glioma	0.0025	0.00526	CcSEcCtD
Fondaparinux sodium—Anorexia—Carmustine—malignant glioma	0.00248	0.00523	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Temozolomide—malignant glioma	0.00247	0.0052	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Temozolomide—malignant glioma	0.00246	0.00519	CcSEcCtD
Fondaparinux sodium—Skin disorder—Temozolomide—malignant glioma	0.00244	0.00515	CcSEcCtD
Fondaparinux sodium—Hypotension—Carmustine—malignant glioma	0.00243	0.00512	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Temozolomide—malignant glioma	0.00243	0.00512	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—ANGPT2—malignant glioma	0.00243	0.00462	CbGpPWpGaD
Fondaparinux sodium—Anorexia—Temozolomide—malignant glioma	0.0024	0.00505	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—KNG1—malignant glioma	0.00237	0.00451	CbGpPWpGaD
Fondaparinux sodium—Insomnia—Carmustine—malignant glioma	0.00235	0.00496	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—XBP1—malignant glioma	0.00234	0.00446	CbGpPWpGaD
Fondaparinux sodium—Paraesthesia—Carmustine—malignant glioma	0.00234	0.00492	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—IFNA2—malignant glioma	0.00232	0.00442	CbGpPWpGaD
Fondaparinux sodium—Dyspnoea—Carmustine—malignant glioma	0.00232	0.00489	CcSEcCtD
Fondaparinux sodium—Somnolence—Carmustine—malignant glioma	0.00231	0.00487	CcSEcCtD
Fondaparinux sodium—Insomnia—Temozolomide—malignant glioma	0.00227	0.00479	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Carmustine—malignant glioma	0.00226	0.00477	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Temozolomide—malignant glioma	0.00226	0.00476	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Carmustine—malignant glioma	0.00225	0.00473	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Temozolomide—malignant glioma	0.00224	0.00472	CcSEcCtD
Fondaparinux sodium—Somnolence—Temozolomide—malignant glioma	0.00223	0.00471	CcSEcCtD
Fondaparinux sodium—Pain—Carmustine—malignant glioma	0.00222	0.00469	CcSEcCtD
Fondaparinux sodium—Constipation—Carmustine—malignant glioma	0.00222	0.00469	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Temozolomide—malignant glioma	0.00221	0.00466	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—SOD1—malignant glioma	0.0022	0.00419	CbGpPWpGaD
Fondaparinux sodium—Decreased appetite—Temozolomide—malignant glioma	0.00219	0.00461	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00217	0.00457	CcSEcCtD
Fondaparinux sodium—Fatigue—Temozolomide—malignant glioma	0.00217	0.00457	CcSEcCtD
Fondaparinux sodium—Pain—Temozolomide—malignant glioma	0.00215	0.00453	CcSEcCtD
Fondaparinux sodium—Constipation—Temozolomide—malignant glioma	0.00215	0.00453	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Carmustine—malignant glioma	0.00214	0.00452	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Carmustine—malignant glioma	0.00213	0.00448	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—HIST1H3B—malignant glioma	0.0021	0.004	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—MYB—malignant glioma	0.00208	0.00396	CbGpPWpGaD
Fondaparinux sodium—Feeling abnormal—Temozolomide—malignant glioma	0.00207	0.00437	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Carmustine—malignant glioma	0.00206	0.00433	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Carmustine—malignant glioma	0.00206	0.00433	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Temozolomide—malignant glioma	0.00206	0.00433	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—PTK2—malignant glioma	0.00202	0.00384	CbGpPWpGaD
Fondaparinux sodium—Urticaria—Temozolomide—malignant glioma	0.002	0.00421	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Temozolomide—malignant glioma	0.00199	0.00419	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Temozolomide—malignant glioma	0.00199	0.00419	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Carmustine—malignant glioma	0.00192	0.00404	CcSEcCtD
Fondaparinux sodium—Asthenia—Carmustine—malignant glioma	0.00187	0.00393	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Temozolomide—malignant glioma	0.00185	0.0039	CcSEcCtD
Fondaparinux sodium—Asthenia—Temozolomide—malignant glioma	0.0018	0.0038	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Carmustine—malignant glioma	0.00178	0.00375	CcSEcCtD
Fondaparinux sodium—Pruritus—Temozolomide—malignant glioma	0.00178	0.00375	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—SPHK1—malignant glioma	0.00174	0.00331	CbGpPWpGaD
Fondaparinux sodium—Dizziness—Carmustine—malignant glioma	0.00172	0.00363	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Temozolomide—malignant glioma	0.00172	0.00363	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—PDGFB—malignant glioma	0.0017	0.00323	CbGpPWpGaD
Fondaparinux sodium—Dizziness—Temozolomide—malignant glioma	0.00166	0.0035	CcSEcCtD
Fondaparinux sodium—Vomiting—Carmustine—malignant glioma	0.00165	0.00349	CcSEcCtD
Fondaparinux sodium—Rash—Carmustine—malignant glioma	0.00164	0.00346	CcSEcCtD
Fondaparinux sodium—Dermatitis—Carmustine—malignant glioma	0.00164	0.00345	CcSEcCtD
Fondaparinux sodium—Headache—Carmustine—malignant glioma	0.00163	0.00343	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—H3F3A—malignant glioma	0.00162	0.00309	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—CAV1—malignant glioma	0.00161	0.00306	CbGpPWpGaD
Fondaparinux sodium—Vomiting—Temozolomide—malignant glioma	0.0016	0.00337	CcSEcCtD
Fondaparinux sodium—Rash—Temozolomide—malignant glioma	0.00159	0.00334	CcSEcCtD
Fondaparinux sodium—Dermatitis—Temozolomide—malignant glioma	0.00158	0.00334	CcSEcCtD
Fondaparinux sodium—Headache—Temozolomide—malignant glioma	0.00157	0.00332	CcSEcCtD
Fondaparinux sodium—Nausea—Carmustine—malignant glioma	0.00155	0.00326	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—F2—malignant glioma	0.00153	0.00291	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—FN1—malignant glioma	0.00153	0.00291	CbGpPWpGaD
Fondaparinux sodium—Nausea—Temozolomide—malignant glioma	0.00149	0.00315	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—PIK3CG—malignant glioma	0.00146	0.00279	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—EGF—malignant glioma	0.00145	0.00276	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PTPN11—malignant glioma	0.00144	0.00274	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—F2—malignant glioma	0.00143	0.00273	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—AKT2—malignant glioma	0.00134	0.00255	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—KNG1—malignant glioma	0.00134	0.00255	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—IFNA2—malignant glioma	0.00131	0.00249	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PIK3CD—malignant glioma	0.00129	0.00245	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—SOD1—malignant glioma	0.00124	0.00237	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—BCHE—malignant glioma	0.0012	0.00228	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—FBXW7—malignant glioma	0.00118	0.00225	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—RAF1—malignant glioma	0.00115	0.00219	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PTK2—malignant glioma	0.00114	0.00217	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PIK3CB—malignant glioma	0.00112	0.00214	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—IL2—malignant glioma	0.00103	0.00196	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PDGFB—malignant glioma	0.000959	0.00182	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—CAV1—malignant glioma	0.000909	0.00173	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—VEGFA—malignant glioma	0.000876	0.00167	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—FN1—malignant glioma	0.000865	0.00165	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—F2—malignant glioma	0.000865	0.00165	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PIK3CG—malignant glioma	0.000828	0.00158	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—EGF—malignant glioma	0.000818	0.00156	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PTPN11—malignant glioma	0.000813	0.00155	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—AKT2—malignant glioma	0.000757	0.00144	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—KRAS—malignant glioma	0.000745	0.00142	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PIK3CD—malignant glioma	0.000728	0.00138	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PIK3CA—malignant glioma	0.000684	0.0013	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—F2—malignant glioma	0.00068	0.00129	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—TP53—malignant glioma	0.000662	0.00126	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—RAF1—malignant glioma	0.00065	0.00124	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PIK3CB—malignant glioma	0.000634	0.00121	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—IL2—malignant glioma	0.000583	0.00111	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—MMP2—malignant glioma	0.000577	0.0011	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—AKT1—malignant glioma	0.000559	0.00106	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—VEGFA—malignant glioma	0.000495	0.000942	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—CXCL8—malignant glioma	0.000479	0.000912	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—KRAS—malignant glioma	0.000421	0.000801	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PIK3CA—malignant glioma	0.000387	0.000736	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—TP53—malignant glioma	0.000374	0.000712	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—AKT1—malignant glioma	0.000316	0.000601	CbGpPWpGaD
